HB561 would create a new telepharmacy authorization in Hawaii law for certain pharmacies connected to federally defined “covered entities,” including those participating in the federal 340B Drug Pricing Program. Under the bill, a registered pharmacist who is contracted with a covered entity could oversee the filling or receipt of prescriptions through telehealth and an interactive telecommunications system, so long as the patient is physically located at a facility operated by the covered entity, the facility has obtained or sought a pharmacy license relocation, and the supervising pharmacist is not physically present at that facility.
The bill also amends the existing pharmacist-in-charge statute to make clear that the general rule requiring a pharmacist’s personal and immediate charge does not apply in the new telepharmacy circumstance created by the bill. In effect, it carves out a limited exception to the prohibition on filling, compounding, or receiving prescriptions during a pharmacist’s absence, while leaving the rest of chapter 461 intact. The measure takes effect upon approval and applies prospectively only, without affecting prior rights, duties, or proceedings.
Impact
HB561 would amend chapter 461, Hawaii Revised Statutes, by adding a new telepharmacy section and by revising section 461-9 to recognize the new exception. It would expand the circumstances under which prescriptions may be supervised remotely, specifically for medically underserved patients served by covered entities, and would align state pharmacy practice rules with telehealth-based dispensing oversight. The bill primarily affects registered pharmacists, covered entities, and facilities seeking pharmacy licensure or relocation tied to 340B-related services.
Sentiment
The available record suggests generally favorable or at least supportive treatment of the bill, as indicated by its introduction and referral without recorded opposition in the provided materials. The bill’s framing emphasizes access to care for medically underserved patients and modernizing pharmacy services through telehealth, which typically signals a policy goal likely to receive support from health access advocates and providers serving underserved communities. No committee testimony or vote record was provided, so the level of support or opposition cannot be measured beyond the bill’s procedural progress.
Contention
The main policy issue is the balance between expanding access through remote pharmacist supervision and preserving traditional safeguards requiring a pharmacist’s physical presence and direct control over pharmacy operations. Potential concerns may include patient safety, oversight of prescription handling, and whether telepharmacy should be limited to covered entities and facilities with pharmacy licensure actions underway. Any opposition would likely come from those worried about loosening pharmacy supervision standards, while supporters would likely emphasize improved access in medically underserved areas and the practical use of telehealth.
Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.